Oncology, Haematology and BMT Pharmacy Unit, Pharmacy and Compounding Section, Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania
Oncology, Haematology and BMT Pharmacy Unit, Pharmacy and Compounding Section, Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.
BMJ Open. 2024 Nov 13;14(11):e083842. doi: 10.1136/bmjopen-2023-083842.
This study assessed the trends and patterns of antimicrobial consumption (AMC) from 2020 to 2021, 2021-2022 and 2022-2023 at the Benjamin Mkapa Zonal Referral Hospital (BMH) in Dodoma, Tanzania.
A retrospective cross-sectional study was conducted to collect AMC data for three financial years with respective denominators. The data were computed using the AMC Tool 2019 v1.9.0 and defined daily dose per 1000 inhabitants per day (DID).
The BMH, Dodoma, Tanzania.
This study surveyed quantities of antimicrobials procured at the BMH. It did not have any human participants.
AMC was quantified in DID. The comparisons were made based on the DID of all surveyed antimicrobials, taking into account oral and parenteral administration and based on pharmacological classes. Further, DIDs were presented based on the 2023 WHO Access (A), Watch (W) and Reserve (R) (AWaRe) classification.
In 29 assessed antimicrobials, the DIDs for 2020-2021, 2021-2022 and 2022-2023 were 3.0852, 3.5892 and 3.9213, respectively. The average DID per year was 3.5319, with a mean of 2.4207±1.9765 DID per year. The topmost consumed antimicrobials over the 3 years (doxycycline, azithromycin, amoxicillin/beta-lactamase inhibitors, ampicillin/cloxacillin, amoxicillin/flucloxacillin, ceftriaxone, nitrofurantoin and clarithromycin) account over 90% of consumption. The most highly consumed therapeutic classes were beta-lactam antibacterial penicillins (34.71%), macrolides, lincosamides, streptogramins and others (25.75%), followed by tetracycline (23.88%). The AWaRe categorisation and antimicrobials not recommended (ANR) distribution were as follows: Access-51.61%, Watch-31.96%, Reserve-0.00%, and ANR-16.43%, respectively.
For every 1000 patients attending the BMH per day, our study found 2.4207±1.9765 DIDs of an antimicrobial were consumed. The most consumed antimicrobials include doxycycline, azithromycin, amoxicillin/beta-lactamase inhibitor, ceftriaxone and metronidazole. To combat antimicrobial resistance effectively, it is imperative to institute a hospital policy for antimicrobial stewardship that prioritises the utilisation of a hospital formulary and antibiograms for the procurement of antimicrobials at the BMH.
本研究评估了 2020 年至 2021 年、2021 年至 2022 年和 2022 年至 2023 年在坦桑尼亚多多马本杰明·姆卡帕地区转诊医院(BMH)的抗菌药物使用趋势和模式。
采用回顾性横断面研究方法,收集了三个财政年度的抗菌药物使用数据,并有各自的分母。数据使用 2019 年版抗菌药物使用工具(AMC Tool 2019 v1.9.0)和定义的每日剂量(DID)/1000 居民/天进行计算。
坦桑尼亚多多马的 BMH。
本研究调查了 BMH 采购的抗菌药物数量。它没有任何人类参与者。
以 DID 表示抗菌药物的使用情况。根据所有调查抗菌药物的 DID 进行比较,考虑到口服和肠胃外给药,并根据药理学分类进行比较。此外,根据 2023 年世卫组织获取(A)、观察(W)和储备(R)(AWaRe)分类,按 DID 进行呈现。
在所评估的 29 种抗菌药物中,2020-2021 年、2021-2022 年和 2022-2023 年的 DID 分别为 3.0852、3.5892 和 3.9213。每年的平均 DID 为 3.5319,平均每年 2.4207±1.9765 DID。过去 3 年中消耗量最高的前 5 种抗菌药物(多西环素、阿奇霉素、阿莫西林/β-内酰胺酶抑制剂、氨苄西林/氯唑西林、阿莫西林/氟氯西林、头孢曲松、呋喃妥因和克拉霉素)占消耗量的 90%以上。消耗量最高的治疗类别是β-内酰胺类抗菌青霉素(34.71%)、大环内酯类、林可酰胺类、链阳性菌素类和其他(25.75%),其次是四环素类(23.88%)。AWaRe 分类和不推荐使用的抗菌药物(ANR)分布如下:可获取类-51.61%、观察类-31.96%、储备类-0.00%、不推荐使用类-16.43%。
在每天有 1000 名患者就诊的 BMH,我们的研究发现每天消耗 2.4207±1.9765 DID 的抗菌药物。消耗量最高的抗菌药物包括多西环素、阿奇霉素、阿莫西林/β-内酰胺酶抑制剂、头孢曲松和甲硝唑。为了有效对抗抗菌药物耐药性,必须在 BMH 制定抗菌药物管理医院政策,优先使用医院处方集和抗生素图来采购抗菌药物。